Admission Date:  [**2179-10-5**]              Discharge Date:   [**2179-10-8**]   Service: CARDIOTHORACIC  Allergies: Heparin Agents / Ciprofloxacin  Attending:[**First Name3 (LF) 281**] Chief Complaint: shortness of breath, respiratory distress, requiring intubation  Major Surgical or Invasive Procedure: [**10-6**]: Rigid bronchoscopy.
Metallic stent placement   History of Present Illness: 88M with metastatic esophageal cancer with erosion/compression of trachea p/w SOB now intubated.
Patient tranferred from [**Last Name (un) 1724**] for Interventional Pulmonary evaluation, treatment and procedure.
Past Medical History: PMH: esophageal ca s/p radiation and chemo, MRSA pneumnia, c. dif, anemia, hyponatremia, s/p G-tube   Physical Exam: General-ill appearing elderly male in NAD, extubated.
Neuro- interactive, grossly intact  Pertinent Results: [**2179-10-5**] 10:23PM   PT-13.5* PTT-34.3 INR(PT)-1.2* [**2179-10-5**] 10:23PM   PLT COUNT-235 [**2179-10-5**] 10:23PM   WBC-13.1* RBC-3.23* HGB-10.3* HCT-30.7* MCV-95 MCH-31.9 MCHC-33.6 RDW-13.9 [**2179-10-5**] 10:23PM   VANCO-11.1 [**2179-10-5**] 10:23PM   calTIBC-190* FERRITIN-621* TRF-146* [**2179-10-5**] 10:23PM   ALBUMIN-3.4 CALCIUM-8.9 PHOSPHATE-2.3* MAGNESIUM-2.3 IRON-29* [**2179-10-5**] 10:23PM   GLUCOSE-137* UREA N-14 CREAT-0.7 SODIUM-142 POTASSIUM-3.7 CHLORIDE-106 TOTAL CO2-29 ANION GAP-11 Hematology   COMPLETE BLOOD COUNT WBC RBC Hgb Hct MCV MCH MCHC RDW Plt Ct [**2179-10-7**] 04:37AM    12.0* 2.81* 9.0* 26.9* 96 32.1* 33.6 13.7 203   BASIC COAGULATION (PT, PTT, PLT, INR) PT PTT Plt Ct INR(PT) [**2179-10-7**] 04:37AM        203 [**2179-10-7**] 04:37AM    14.0* 42.1*   1.2*  Chemistry   RENAL & GLUCOSE Glucose UreaN Creat Na K Cl HCO3 AnGap [**2179-10-7**] 04:37AM    125* 7 0.6 137 3.7 105 27 9   ENZYMES & BILIRUBIN ALT AST LD(LDH) CK(CPK) AlkPhos Amylase TotBili DirBili [**2179-10-7**] 04:37AM          77   CPK ISOENZYMES CK-MB cTropnT [**2179-10-7**] 04:37AM    NotDone1 0.04*2 1 NotDone CK-MB NOT PERFORMED, TOTAL CK < 100  2 CTROPNT > 0.10 NG/ML SUGGESTS ACUTE MI   CHEMISTRY TotProt Albumin Globuln Calcium Phos Mg UricAcd Iron  [**2179-10-7**] 04:37AM          8.1* 2.6* 2.0 HEMATOLOGIC calTIBC Ferritn TRF [**2179-10-5**] 10:23PM    190* 621* 146* ANTIBIOTICS Vanco [**2179-10-5**] 10:23PM    11.11 1 UPDATED REFERENCE RANGE AS OF [**2179-9-22**] == REPRESENTS THERAPEUTIC TROUGH  Blood Gas   BLOOD GASES Type Temp Rates Tidal V PEEP FiO2 O2 Flow pO2 pCO2 pH calTCO2 Base XS Intubat Vent [**2179-10-7**] 06:44AM    ART             116* 38 7.45 27 3 [**2179-10-7**] 01:03AM    ART 38.1 /22 300 5 40   95 42 7.42 28 2 INTUBATED SPONTANEOU1  RADIOLOGY   Preliminary Report CT CHEST W/O CONTRAST  [**2179-10-6**] 2:50 AM Reason: [**Hospital **] [**Hospital 93**] MEDICAL CONDITION: 88 year old man with esophageal mass eroding into trachea REASON FOR THIS EXAMINATION: ?
TECHNIQUE: MDCT acquired images of the chest without the use of intravenous contrast material.
There is bronchiectasis and surrounding peribronchial fibrotic thickening in the right upper lobe of uncertain significance.
The patient is status post midline sternotomy, apparently performed for treatment of motor vehicle accident trauma, according to the CareWeb notes.
The mass is also invading the posterior tracheal wall and causing luminal narrowing distal to the endotracheal tube.
Bronchiectasis with peribronchial, likely chronic, thickening in the right upper lobe of uncertain etiology.
IMPRESSION: AP chest compared to [**10-6**]: Endotracheal tube has been removed, leaving a mild subglottic edema.
Tracheal stent at the level of the aortic arch is unchanged in position, and the left lung volumes are lower, with new left lower lobe atelectasis.
Mediastinal contours are unchanged, although the extent of the upper esophageal mass is not fully apparent on plain radiographs.
Patient admitted [**2179-10-5**] to ICU for ongoing critical management.
Night of admission, CT of neck/chest done, pre-op for OR- rigid bronchoscopy, possible stent placement.
To OR w/ Inter Pul for:Rigid bronchoscopy, Flexible bronchoscopy,Balloon dilatation, Metallic stent placement.
Patient re-intubated into metallic stent post procedure for overnight observation.
T- 100.6; Vanco HD#3/PPD1- Patient stable in early am, sedation weaned w/o complication.
Pt stable post- procedure and ready for transfer back to acute/critical referring facility.
Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed.
Albuterol-Ipratropium 103-18 mcg/Actuation Aerosol Sig: Two (2) Puff Inhalation Q4H (every 4 hours).
Fluticasone 110 mcg/Actuation Aerosol Sig: Two (2) Puff Inhalation [**Hospital1 **] (2 times a day).
Albuterol Sulfate 0.083 % Solution Sig: One (1) neb Inhalation Q3-4H (Every 3 to 4 Hours) as needed.
Ipratropium Bromide 0.02 % Solution Sig: One (1) neb Inhalation Q6H (every 6 hours).
Pantoprazole 40 mg IV Q24H 10.
Potassium Chloride 20 mEq / 250 ml D5W IV PRN K<4 11.
Magnesium Sulfate 2 gm / 100 ml D5W IV PRN Mg<2 12.
Vancomycin HCl 1000 mg IV Q 12H check after third dose 13.
Metoprolol 5 mg IV Q4H hold for hr<60 and sbp<100 14.
Fentanyl Citrate 25-100 mcg IV Q2H:PRN 15.
Ceftriaxone 1 gm IV Q24H 16.
Insulin Regular Human 100 unit/mL Solution Sig: as dir units Injection ASDIR (AS DIRECTED): sliding scale.
PMH: esophageal ca s/p radiation and chemo, MRSA pneumnia, c. difficile, anemia, hyponatremia, s/p G-tube.
Contact [**Name6 (MD) **] [**Name8 (MD) **], MD, [**Hospital1 18**], Interventional Pulmonary- [**Telephone/Fax (1) 3020**] for any post procedure issues or questions  Followup Instructions: Follow-up per instruction by [**Name6 (MD) **] [**Name8 (MD) **], MD, [**Hospital1 18**]-[**Telephone/Fax (1) 3020**]                                 [**Name6 (MD) **] [**Name8 (MD) **] MD [**MD Number(2) 286**]
